144.01

Donor leverage and equitable access to essential medicines
Chee Khoon Chan, Universiti Sains Malaysia, Malaysia

144.02

Preparing for HPV vaccination in South Africa: Key challenges and opinions
Jane Harries, University of Cape Town, South Africa; Jennifer Moodley, University of Cape Town, South Africa; Mark A. Barone, Engender Health, USA; Sumaya Mall, University of Cape Town, South Africa; Edina Sinanovic, University of Cape Town, South Africa

144.03

Entry and price response in markets without patent protection: The case of pharmaceuticals in Argentina
Daniel A. Maceira, Center for the Study of State and Society (CEDES), Argentina

144.04

Study on prevalence of self medication in a south Indian district
Habeeb Ibrahim Abdul Razack, Sikkim Manipal University, India; Jegan RS, Quest Life Sciences Pvt Ltd, India; Narmadha Sambasivam, Quest Life Sciences Pvt Ltd, India; Babu J, GVK Biosciences Pvt Ltd, India; Mathar Sahib Abdul Razack, Devandra College of Physiotherapy, India

144.05

Medical devices alerts as an input data for the health technology assessment
Carla J. F. Cruz, The Brazilian Health Surveillance Agency, Brazil; Evelinda Trindade, University of São Paulo - USP, Brazil; Stela Melchior, The Brazilian Health Surveillance Agency, Brazil

144.06

The perceptions of community pharmacists of herbal medicine in Ibadan, Nigeria
Hamidu A. Oluyedun, Oyo State Hospital Management Board, Nigeria

144.07

Program of high cost medicines in the Brazilian health system, 2000-2004
Francisco A. Acurcio, Federal University of Minas Gerais, Brazil; Eli I.G. Andrade, Federal University of Minas Gerais, Brazil; Mariangela L. Cherchiglia, Federal University of Minas Gerais, Brazil; Augusto A. Guerra Jr., Federal University of Minas Gerais, Brazil; Cristina R. Brandão, Federal University of Minas Gerais, Brazil; Alessandra M. Almeida, Federal University of Minas Gerais, Brazil; Odilon V. Queiroz, Federal University of Minas Gerais, Brazil; Grazielle D. Silva, Minas Gerais State Health Secretary, Brazil; Daniele A. Szuster, Brazilian Ministry of Health; Daniel R. Faleiros, Brazilian Ministry of Health; Elias A. Jorge, Brazilian Ministry of Health

144.08

Automedication
Adriano Antonio da Silva Pedrosa-Moreira, Escola Nacional de Saúde Pública - ENSP/FIOCRUZ, Brazil; Klaysa Moreira Ramos-Pedrosa, Escola Nacional de Saúde Pública - ENSP/FIOCRUZ, Brazil; Antonio Piranema de Mascarenhas Pedrosa, Universidade Federal de Alagoas (UFAL), Brazil

144.09

Contribution to pharmacosurveillance through the study of prevalence of the use of allopathics and phytotherapics in communities assisted by peslutan 2004
Adriano Antonio da Silva Pedrosa-Moreira, Escola Nacional de Saúde Pública - ENSP/FIOCRUZ, Brazil; Klaysa Moreira Ramos-Pedrosa, Escola Nacional de Saúde Pública - ENSP/FIOCRUZ, Brazil; Antonio Piranema de Mascarenhas Pedrosa, Universidade Federal de Alagoas (UFAL), Brazil

144.10

Pharmaceutical public services provided by districts of the state of Santa Catarina – Brazil
Silvana Nair Leite, UNIVALI/ MINISTÉRIO DA SAÚDE, Brazil; Ana Paula Veber, UNIVALI, Brazil; Eliana Dielh, Universidade Federal de Santa Catarina, Brazil; Elisete Navas Sanches Prospero, UNIVALI, Brazil

144.11

Scarcity and abundance: Medical imaging equipment supply in Brazil
Marco Antonio Ratzsch Andreazzi, Brazilian Institute of Geography and Statistics, Brazil; Maria de Fatima Siliansky Andreazzi, Federal University of Rio de Janeiro, Brazil

144.12

The role of courts in providing access to health care services: The case of the supply of medicine in the Brazilian public health system
Danielle Borges, EUROPEAN UNIVERSITY INSTITUTE, Italy

144.13

Medicine access and pharmaceutical services evaluation in Brazilian health care system: A review
Rosana I. Santos, Federal University of Santa Catarina, Brazil; Carine R. Blatt, University of South of Santa Catarina, Brazil; Junior A. Rosa, Federal University of Santa Catarina, Brazil; Vanessa de B. Sartor, Municipal Health Secretariat, Brazil; Maria C. Calvo, Federal University of Santa Catarina, Brazil; Mareni R. Farias, Federal University of Santa Catarina, Brazil

144.14

Impact of the health public politics to guarantee the drugs access in Brazil: The program of high cost drugs dispensing
Claudia S. C. da Cunha, Ministy of Health of Brazil, Brazil; Eliane C. Correa, Ministy of Health of Brazil, Brazil; Giselle S. Calado, Ministy of Health of Brazil, Brazil; Dirceu B. A. Barbano, Ministy of Health of Brazil, Brazil

144.15

Impact of the health public politics to guarantee the drugs access in Brazil: The measure DHS experience
Giselle S. Calado, Ministy of Health of Brazil, Brazil; Claudia S. C. da Cunha, Ministy of Health of Brazil, Brazil; Dirceu B. A. Barbano, Ministy of Health of Brazil, Brazil

144.16

The work context and occupational health: An ethnographic study in a university hospital, Southeast Brazil
Lucas P. Melo, University of Campinas (UNICAMP), Brazil; Marcos S. Queiroz, University of Campinas (UNICAMP), Brazil

144.17

Study of the anti-mycobacterial and cytotoxicity of medicinal plants used in traditional treatment of tuberculosis in northern Mexico
Oscar Beltran, University of Texas at El Paso, USA; MM Weigel, University of Texas at El Paso, USA; Rodrigo Xavier Armijos, University of Texas at El Paso, USA

144 Poster: Public Health Approach to Pharmaceuticals and Medical Supplies